BridgeMD
New treatment option for Atopic Dermatitis (AD)
Official title A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov ID: NCT07105488
What this study is testing
What is BFB759?
BFB759 is an investigational medicine, being studied as a potential treatment for atopic dermatitis (ad).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB759 works and how safe it is compared with a placebo.
- Phase 2: a mid-size study of how well it works
- You might receive a placebo (an inactive treatment) instead of the study drug. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Are adults (18-75) with a diagnosis of atopic dermatitis for at least one year.
- Have moderate to severe disease not adequately controlled by topical treatments.
- Are willing to follow study instructions, attend regular visits, and avoid certain other medications during the study.
You likely can't join if
- Have certain infections or other immune conditions.
- Recently used medications that could interfere with the study.
- Are pregnant or breastfeeding.
The study team makes the final eligibility decision.
Where it's taking place
- Phoenix, Arizona, United States
- Encino, California, United States
- Huntington Beach, California, United States
- Lancaster, California, United States
- Los Angeles, California, United States
- Rocklin, California, United States
- West Hills, California, United States
- Boca Raton, Florida, United States
- Coral Gables, Florida, United States
- Fort Lauderdale, Florida, United States
- Margate, Florida, United States
- North Miami Beach, Florida, United States
- Sweetwater, Florida, United States
- Tampa, Florida, United States
- Winter Park, Florida, United States
- Douglasville, Georgia, United States
- Plainfield, Indiana, United States
- Covington, Louisiana, United States
- Metairie, Louisiana, United States
- Brighton, Massachusetts, United States
+ 57 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Phoenix, Arizona, United States; Encino, California, United States; Huntington Beach, California, United States; Lancaster, California, United States; Los Angeles, California, United States; Rocklin, California, United States and 71 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.